What is Strados Labs?
Strados Labs is at the forefront of medical technology, specializing in the development of smart sensor platforms that leverage machine learning and proprietary algorithms. Their core mission is to detect and predict compounding conditions associated with serious, chronic respiratory diseases, thereby enhancing patient lives globally. The company's flagship product, RESP, a first-of-its-kind smart sensor platform for respiratory health, has recently achieved significant regulatory milestones, including CE Mark approval and FDA Class II 510(k) clearance. Strados Labs is actively expanding its pipeline to address other chronic diseases beyond respiratory conditions, with plans to incorporate heart failure management into its offerings. The company's strategic focus remains on critical areas such as asthma, COPD, and infectious respiratory diseases, including COVID and RSV.
How much funding has Strados Labs raised?
Strados Labs has raised a total of $6.4M across 3 funding rounds:
Unspecified
$1.8M
Debt
$117K
Other Financing Round
$4.5M
Unspecified (2019): $1.8M with participation from SOSV, Cathexis Ventures, and Ben Franklin Technology Partners Companies
Debt (2021): $117K led by PPP
Other Financing Round (2022): $4.5M supported by Blu Venture Investors, Wavemaker Three-Sixty Health, cultivate, Broad Street Angels, and SOSV
Key Investors in Strados Labs
Blu Venture Investors
Blu Venture Investors is an early-stage venture capital fund specializing in cybersecurity investments, founded by former operators with extensive experience in scaling companies from inception to exit. The firm focuses on supporting innovators who develop tools and platforms to enhance digital security, particularly those leveraging AI to combat evolving threats.
Wavemaker Three-Sixty Health
Wavemaker Three-Sixty Health is a leading U.S. venture capital fund that focuses exclusively on early-stage healthcare startups, investing in promising companies across North America. The firm is backed by Limited Partners with extensive experience in the healthcare industry, enabling it to identify and support transformative healthcare innovations.
Broad Street Angels
Broad Street Angels is a Philadelphia-based angel investment club that focuses on providing funding opportunities for entrepreneurs in the Mid-Atlantic region. With nearly 125 accredited investors, the club has invested over $7.75 million in 30 companies since its inception in 2017.
What's next for Strados Labs?
With the recent infusion of major strategic investment, Strados Labs is poised for accelerated growth and product development. The company's focus on obtaining regulatory clearances and expanding its platform capabilities indicates a clear trajectory towards scaling its operations and market penetration. Future endeavors will likely involve further clinical validation, broader commercialization of the RESP platform, and the introduction of new sensor solutions for other chronic conditions. This strategic financing will be instrumental in supporting R&D initiatives, expanding the team, and forging key partnerships to solidify Strados Labs' position as a leader in predictive chronic disease management technology.
See full Strados Labs company page
